Portal de investigação
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Aimo, A
- Al-Mohammad, A
- Keramida, K
- Ben Gal, T
- Dorbala, S
- Todiere, G
- Cameli, M
- Barison, A
- Bayes-Genis, A
- von Bardeleben, RS
- Bucciarelli-Ducci, C
- Delgado, V
- Mordi, IR
- Seferovic, P
- Savarese, G
- Celutkiene, J
- Rapezzi, C
- Emdin, M
- Coats, A
- Metra, M
- Rosano, G
Unidades de investigação
Abstract
Left ventricular (LV) hypertrophy consists in an increased LV wall thickness. LV hypertrophy can be either secondary, in response to pressure or volume overload, or primary, i.e. not explained solely by abnormal loading conditions. Primary LV hypertrophy may be due to gene mutations or to the deposition or storage of abnormal substances in the extracellular spaces or within the cardiomyocytes (more appropriately defined as pseudohypertrophy). LV hypertrophy is often a precursor to subsequent development of heart failure. Cardiovascular imaging plays a key role in the assessment of LV hypertrophy. Echocardiography, the first-line imaging technique, allows a comprehensive assessment of LV systolic and diastolic function. Cardiovascular magnetic resonance provides added value as it measures accurately LV and right ventricular volumes and mass and characterizes myocardial tissue properties, which may provide important clues to the final diagnosis. Additionally, scintigraphy with bone tracers is included in the diagnostic algorithm of cardiac amyloidosis. Once the diagnosis is established, imaging findings may help predict future disease evolution and inform therapy and follow-up. This consensus document by the Heart Failure Association of the European Society of Cardiology provides an overview of the role of different cardiac imaging techniques for the differential diagnosis and management of patients with LV hypertrophy.
Dados da publicação
- ISSN/ISSNe:
- 1388-9842, 1879-0844
- Tipo:
- Article
- Páginas:
- 1493-1506
- DOI:
- 10.1002/ejhf.2997
European Journal of Heart Failure Wiley-Blackwell
Citações Recebidas na Web of Science: 1
Documentos
- Não há documentos
Filiações
Keywords
- Imaging; Hypertrophy; Cardiomyopathy; Diagnosis; Consensus document
Proyectos asociados
Loop diuretic suspension in Chronic Heart Failure patients - a retrospective study
Investigador Principal: Brenda Eugénia Carvalho de Moura Cardoso
Estudo Clínico Académico (Loop diuretic) . 2023
Citar a publicação
Moura B,Aimo A,Al A,Keramida K,Ben T,Dorbala S,Todiere G,Cameli M,Barison A,Bayes A,von RS,Bucciarelli C,Delgado V,Mordi IR,Seferovic P,Savarese G,Celutkiene J,Rapezzi C,Emdin M,Coats A,Metra M,Rosano G. Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2023. 25. (9):p. 1493-1506. IF:18,200. (1).
